{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:13:36Z","timestamp":1788437616394,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"47","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["210101207"],"award-info":[{"award-number":["210101207"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31760313"],"award-info":[{"award-number":["31760313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2022,11,18]]},"DOI":"10.1038\/s41388-022-02477-6","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T12:08:14Z","timestamp":1666008494000},"page":"5107-5120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The NQO1\/p53\/SREBP1 axis promotes hepatocellular carcinoma progression and metastasis by regulating Snail stability"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8634-9590","authenticated-orcid":false,"given":"Xinyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0279-3166","authenticated-orcid":false,"given":"Zhenhua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"2477_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","volume":"72","author":"AG Singal","year":"2020","unstructured":"Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: New trends. J Hepatol. 2020;72:250\u201361.","journal-title":"J Hepatol"},{"key":"2477_CR2","unstructured":"Long MT, Noureddin M, Lim JK AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review. Gastroenterology. 2022: S0016-5085(22)00628-X."},{"key":"2477_CR3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jhep.2018.02.003","volume":"68","author":"F Duan","year":"2018","unstructured":"Duan F, Wu H, Jia D, Wu W, Ren S, Wang L, et al. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis. J Hepatol. 2018;68:1191\u2013202.","journal-title":"J Hepatol"},{"key":"2477_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","volume":"18","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18:293\u2013313.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2477_CR5","doi-asserted-by":"publisher","first-page":"783236","DOI":"10.3389\/fimmu.2021.783236","volume":"12","author":"R Xing","year":"2021","unstructured":"Xing R, Gao J, Cui Q, Wang Q. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma. Front Immunol. 2021;12:783236.","journal-title":"Front Immunol"},{"key":"2477_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, Avgustinova A, Mejetta S, Mart\u00edn M, Castellanos A, Attolini CS, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 2017;541:41\u201345.","journal-title":"Nature"},{"key":"2477_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.49","volume":"6","author":"F Yin","year":"2017","unstructured":"Yin F, Sharen G, Yuan F, Peng Y, Chen R, Zhou X, et al. TIP30 regulates lipid metabolism in hepatocellular carcinoma by regulating SREBP1 through the Akt\/mTOR signaling pathway. Oncogenesis 2017;6:e347.","journal-title":"Oncogenesis"},{"key":"2477_CR8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41575-019-0217-8","volume":"16","author":"L Satriano","year":"2019","unstructured":"Satriano L, Lewinska M, Rodrigues PM, Banales JM, Andersen JB. Metabolic rearrangements in primary liver cancers: cause and consequences. Nat Rev Gastroenterol Hepatol. 2019;16:748\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2477_CR9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-020-2183-2","volume":"580","author":"D Xu","year":"2020","unstructured":"Xu D, Wang Z, Xia Y, Shao F, Xia W, Wei Y, et al. The gluconeogenic enzyme PCK1 phosphorylates INSIG1\/2 for lipogenesis. Nature 2020;580:530\u20135.","journal-title":"Nature"},{"key":"2477_CR10","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/hep.30346","volume":"69","author":"DP Kumar","year":"2019","unstructured":"Kumar DP, Santhekadur PK, Seneshaw M, Mirshahi F, Uram-Tuculescu C, Sanyal AJ. A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma. Hepatology 2019;69:1520\u201334.","journal-title":"Hepatology"},{"key":"2477_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature14557","volume":"524","author":"J Han","year":"2015","unstructured":"Han J, Li E, Chen L, Zhang Y, Wei F, Liu J, et al. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Nature 2015;524:243\u20136.","journal-title":"Nature"},{"key":"2477_CR12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F Rohrig","year":"2016","unstructured":"Rohrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16:732\u201349.","journal-title":"Nat Rev Cancer"},{"key":"2477_CR13","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ng.155","volume":"40","author":"R Fagerholm","year":"2008","unstructured":"Fagerholm R, Hofstetter B, Tommiska J, Aaltonen K, Vrtel R, Syrj\u00e4koski K, et al. NAD(P)H: quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat Genet. 2008;40:844\u201353.","journal-title":"Nat Genet"},{"key":"2477_CR14","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/bjc.2013.357","volume":"109","author":"B Lajin","year":"2013","unstructured":"Lajin B, Alachkar A. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis. Br J Cancer. 2013;109:1325\u201337.","journal-title":"Br J Cancer"},{"key":"2477_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-9966-33-14","volume":"33","author":"Y Yang","year":"2014","unstructured":"Yang Y, Zhang Y, Wu Q, Cui X, Lin Z, Liu S, et al. Clinical implications of high NQO1 expression in breast cancers. J Exp Clin Cancer Res. 2014;33:14.","journal-title":"J Exp Clin Cancer Res"},{"key":"2477_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13593","volume":"7","author":"ET Oh","year":"2016","unstructured":"Oh ET, Kim JW, Kim JM, Kim SJ, Lee JS, Hong SS, et al. NQO1 inhibits proteasome-mediated degradation of HIF-1\u03b1. Nat Commun. 2016;7:13593.","journal-title":"Nat Commun"},{"key":"2477_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-414","volume":"14","author":"Y Ma","year":"2014","unstructured":"Ma Y, Kong J, Yan G, Ren X, Jin D, Jin T, et al. NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix. BMC Cancer. 2014;14:414.","journal-title":"BMC Cancer"},{"key":"2477_CR18","doi-asserted-by":"publisher","first-page":"747282","DOI":"10.3389\/fonc.2021.747282","volume":"11","author":"W Zhao","year":"2021","unstructured":"Zhao W, Jiang L, Fang T, Fang F, Liu Y, Zhao Y, et al. \u03b2-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation. Front Oncol. 2021;11:747282.","journal-title":"Front Oncol"},{"key":"2477_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.humpath.2017.09.002","volume":"69","author":"L Lin","year":"2017","unstructured":"Lin L, Sun J, Tan Y, Li Z, Kong F, Shen Y, et al. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma. Hum Pathol. 2017;69:31\u201337.","journal-title":"Hum Pathol"},{"key":"2477_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/hep.30818","volume":"71","author":"M Dimri","year":"2020","unstructured":"Dimri M, Humphries A, Laknaur A, Elattar S, Lee TJ, Sharma A, et al. NAD(P)H Quinone Dehydrogenase 1 Ablation Inhibits Activation of the Phosphoinositide 3-Kinase\/Akt Serine\/Threonine Kinase and Mitogen-Activated Protein Kinase\/Extracellular Signal-Regulated Kinase Pathways and Blocks Metabolic Adaptation in Hepatocellular Carcinoma. Hepatology 2020;71:549\u201368.","journal-title":"Hepatology"},{"key":"2477_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.canlet.2019.03.054","volume":"453","author":"Y Yang","year":"2019","unstructured":"Yang Y, Zhu G, Dong B, Piao J, Chen L, Lin Z. The NQO1\/PKLR axis promotes lymph node metastasis and breast cancer progression by modulating glycolytic reprogramming. Cancer Lett. 2019;453:170\u201383.","journal-title":"Cancer Lett"},{"key":"2477_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2252-3","volume":"11","author":"R Wang","year":"2020","unstructured":"Wang R, Ma Y, Zhan S, Zhang G, Cao L, Zhang X, et al. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-\u03baB pathway to induce VEGFA expression. Cell Death Dis. 2020;11:55.","journal-title":"Cell Death Dis"},{"key":"2477_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-019-1156-5","volume":"38","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Lu S, Li T, Yu L, Zhang Y, Zeng H, et al. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa\/VEGFR2\/ERK pathway. J Exp Clin Cancer Res. 2019;38:173.","journal-title":"J Exp Clin Cancer Res"},{"key":"2477_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02244-9","volume":"18","author":"J Pasquier","year":"2020","unstructured":"Pasquier J, Ghiabi P, Chouchane L, Razzouk K, Rafii S, Rafii A. Angiocrine endothelium: from physiology to cancer. J Transl Med. 2020;18:52.","journal-title":"J Transl Med"},{"key":"2477_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","volume":"38","author":"C Cheng","year":"2018","unstructured":"Cheng C, Geng F, Cheng X, Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018;38:27.","journal-title":"Cancer Commun (Lond)"},{"key":"2477_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41418-018-0158-8","volume":"26","author":"N Zhang","year":"2019","unstructured":"Zhang N, Zhang H, Liu Y, Su P, Zhang J, Wang X, et al. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1\/2. Cell Death Differ. 2019;26:843\u201359.","journal-title":"Cell Death Differ"},{"key":"2477_CR27","doi-asserted-by":"publisher","first-page":"11280","DOI":"10.1021\/acs.jmedchem.8b01424","volume":"61","author":"X Wu","year":"2018","unstructured":"Wu X, Li X, Li Z, Yu Y, You Q, Zhang X. Discovery of nonquinone substrates for NAD(P)H: quinone oxidoreductase 1 (NQO1) as effective intracellular ROS generators for the treatment of drug-resistant non-small-cell lung cancer. J Med Chem. 2018;61:11280\u201397.","journal-title":"J Med Chem"},{"key":"2477_CR28","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1021\/acs.jmedchem.8b00124","volume":"61","author":"K Zhang","year":"2018","unstructured":"Zhang K, Chen D, Ma K, Wu X, Hao H, Jiang S. NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer. J Med Chem. 2018;61:6983\u20137003.","journal-title":"J Med Chem"},{"key":"2477_CR29","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/mc.20199","volume":"56","author":"AM Lewis","year":"2017","unstructured":"Lewis AM, Ough M, Du J, Tsao MS, Oberley LW, Cullen JJ. Targeting NAD(P)H:Quinone Oxidoreductase (NQO1) in Pancreatic Cancer. Mol Carcinog. 2017;56:1825\u201334.","journal-title":"Mol Carcinog"},{"key":"2477_CR30","doi-asserted-by":"publisher","first-page":"9146528","DOI":"10.1155\/2018\/9146528","volume":"2018","author":"S Luo","year":"2018","unstructured":"Luo S, Lei K, Xiang D, Ye K. NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress. Oxid Med Cell Longev. 2018;2018:9146528.","journal-title":"Oxid Med Cell Longev"},{"key":"2477_CR31","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/cas.14320","volume":"111","author":"M Shimokawa","year":"2020","unstructured":"Shimokawa M, Yoshizumi T, Itoh S, Iseda N, Sakata K, Yugawa K, et al. Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma. Cancer Sci. 2020;111:1228\u201340.","journal-title":"Cancer Sci"},{"key":"2477_CR32","doi-asserted-by":"publisher","first-page":"101320","DOI":"10.1016\/j.redox.2019.101320","volume":"28","author":"CC Pati\u00f1o-Morales","year":"2020","unstructured":"Pati\u00f1o-Morales CC, Soto-Reyes E, Arechaga-Ocampo E, Ortiz-S\u00e1nchez E, Antonio-V\u00e9jar V, Pedraza-Chaverri J, et al. Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines. Redox Biol. 2020;28:101320.","journal-title":"Redox Biol"},{"key":"2477_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ccell.2018.12.012","volume":"35","author":"J Kim","year":"2019","unstructured":"Kim J, Yu L, Chen W, Xu Y, Wu M, Todorova D, et al. Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation. Cancer Cell. 2019;35:191\u2013203.","journal-title":"Cancer Cell"},{"key":"2477_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jmcb\/mjy070","volume":"11","author":"J Liu","year":"2019","unstructured":"Liu J, Zhang C, Hu W, Feng Z. Tumor suppressor p53 and metabolism. J Mol Cell Biol. 2019;11:284\u201392.","journal-title":"J Mol Cell Biol"},{"key":"2477_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18:153\u201361.","journal-title":"Cell Metab"},{"key":"2477_CR36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hep.28368","volume":"63","author":"F Piscaglia","year":"2016","unstructured":"Piscaglia F, Svegliati-Baroni G, Barchetti A, Pecorelli A, Marinelli S, Tiribelli C, et al. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study. Hepatology 2016;63:827\u201338.","journal-title":"Hepatology"},{"key":"2477_CR37","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/hep.30030","volume":"68","author":"C Wang","year":"2018","unstructured":"Wang C, Tong Y, Wen Y, Cai J, Guo H, Huang L, et al. Hepatocellular Carcinoma-Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element-Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth. Hepatology 2018;68:1833\u201350.","journal-title":"Hepatology"},{"key":"2477_CR38","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1158\/2326-6066.CIR-18-0513","volume":"7","author":"PM Santos","year":"2019","unstructured":"Santos PM, Menk AV, Shi J, Tsung A, Delgoffe GM, Butterfield LH. Tumor-Derived \u03b1-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic Cells. Cancer Immunol Res. 2019;7:1001\u201312.","journal-title":"Cancer Immunol Res"},{"key":"2477_CR39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.bbrc.2018.02.097","volume":"504","author":"M Maan","year":"2018","unstructured":"Maan M, Peters JM, Dutta M, Patterson AD. Lipid metabolism and lipophagy in cancer. Biochem Biophys Res Commun. 2018;504:582\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2477_CR40","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/15548627.2019.1644076","volume":"16","author":"Z Deng","year":"2020","unstructured":"Deng Z, Lim J, Wang Q, Purtell K, Wu S, Palomo GM, et al. ALS-FTLD-linked mutations of SQSTM1\/p62 disrupt selective autophagy and NFE2L2\/NRF2 anti-oxidative stress pathway. Autophagy 2020;16:917\u201331.","journal-title":"Autophagy"},{"key":"2477_CR41","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2174\/13816128113199990486","volume":"20","author":"D Guo","year":"2014","unstructured":"Guo D, Bell EH, Mischel P, Chakravarti A. Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des. 2014;20:2619\u201326.","journal-title":"Curr Pharm Des"},{"key":"2477_CR42","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/onc.2015.133","volume":"35","author":"MF Pang","year":"2016","unstructured":"Pang MF, Georgoudaki AM, Lambut L, Johansson J, Tabor V, Hagikura K, et al. TGF-\u03b21-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7\/CCL21-mediated chemotaxis. Oncogene 2016;35:748\u201360.","journal-title":"Oncogene"},{"key":"2477_CR43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/1878-0261.12092","volume":"11","author":"MC Karlsson","year":"2017","unstructured":"Karlsson MC, Gonzalez SF, Welin J, Fuxe J. Epithelialmesenchymal transition in cancer metastasis through the lymphatic system. Mol Oncol. 2017;11:781\u201391.","journal-title":"Mol Oncol"},{"key":"2477_CR44","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.7150\/ijbs.26011","volume":"14","author":"J Lyu","year":"2018","unstructured":"Lyu J, Yang EJ, Head SA, Ai N, Zhang B, Wu C, et al. Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol Trafficking. Int J Biol Sci. 2018;14:1175\u201385.","journal-title":"Int J Biol Sci"},{"key":"2477_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.freeradbiomed.2017.12.036","volume":"116","author":"KR Katikireddy","year":"2018","unstructured":"Katikireddy KR, White TL, Miyajima T, Vasanth S, Raoof D, Chen Y, et al. NQO1 downregulation potentiates menadione-induced endothelial-mesenchymal transition during rosette formation in Fuchs endothelial corneal dystrophy. Free Radic Biol Med. 2018;116:19\u201330.","journal-title":"Free Radic Biol Med"},{"key":"2477_CR46","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/hep.30917","volume":"71","author":"J Liu","year":"2020","unstructured":"Liu J, Wu Z, Han D, Wei C, Liang Y, Jiang T, et al. Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-\u03baB\/Snail Signaling Pathway and Epithelial-Mesenchymal Transition. Hepatology 2020;71:1262\u201378.","journal-title":"Hepatology"},{"key":"2477_CR47","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1111\/cas.14562","volume":"111","author":"X Wang","year":"2020","unstructured":"Wang X, Li N, Han A, Wang Y, Lin Z, Yang Y. Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming. Cancer Sci. 2020;111:4061\u201374.","journal-title":"Cancer Sci"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02477-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T20:08:11Z","timestamp":1668888491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02477-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":47,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2022,11,18]]}},"alternative-id":["2477"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02477-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"assertion":[{"value":"26 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal experiments were conducted in accordance with the regulations of the Institutional Animal Care and Use Committee with the approval of the Ethics Committee of Yanbian University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}